$ Value
$0
Shares
455,000
Price
$0
Filed
Sep 8
Insider
Name
KING THOMAS BRAXTON
Title
—
CIK
0001279309
Roles
Transaction Details
Transaction Date
2025-09-04
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
455,000
Footnotes
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. | Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Represents PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. | Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. | Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.
Filing Info
KING THOMAS BRAXTON's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-09-04 | ACHV | M | $0 |
| 2025-09-04 | ACHV | ▼ | $387K |
| 2025-09-04 | ACHV | M | $0 |
| 2025-06-06 | ACHV | A | $0 |
Other Insiders at ACHV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Oki Mark K
Chief Financial Officer
|
— | — | 2026-01-28 |
|
Stewart Richard Alistair
Chief Executive Officer
|
— | — | 2026-01-28 |
|
Goldberg Andrew D.
CEO and President
|
— | — | 2026-04-18 |
|
Wan Jerry
Principal Accounting Officer
|
— | — | 2026-01-28 |
|
Xinos Jaime
Chief Commercial Officer
|
— | — | 2026-01-28 |
|
Donnelly Craig
Chief Operations Officer
|
— | — | 2026-01-28 |
|
Rubinstein Mark Lawrence
Chief Medical Officer
|
— | — | 2026-01-28 |